FDA Import Refusal 1FX-2262166-8/10002/1 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3000151819

The FDA refused shipment 1FX-2262166-8/10002/1 from Novo Nordisk A/S (Denmark) on Aug 13, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.